Crossmark

National value-based pricing negotiation for oncology drugs — lessons from China

Crossref DOI link: https://doi.org/10.1038/s41571-023-00769-8

Published Online: 2023-05-12

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yuan, Jing https://orcid.org/0000-0003-0906-1822
Li, Minghui https://orcid.org/0000-0003-1909-6260
Lu, Z. Kevin https://orcid.org/0000-0002-6380-0836
License Information

Text and Data Mining valid from 2023-05-12

Version of Record valid from 2023-05-12
More Information

Article History

First Online: 12 May 2023

Competing interests

: The authors declare no competing interests.